5Ferenci P, Fried M, Labrecque D, et al. World Gastroenterology Organization. Hepatocellular carcinoma (HCC):a global perspective [J]. J Clin Gastroenterol, 2010,44 (4) : 239-245.
6Sherman M, Bruix J, Porayko M, et al. AASLD Practice Guidelines Committee. Screening for hepatocellular carcinoma:the rationale for the American Association for the Study of Liver Diseases recommendations [J]. Hepatology, 2012,56(3) :793-796.
7Xu XH,Lu MD,Liu LN,et al. Discrimination between neoplastic and nonneoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound [J]. Br J Radiol,2012,85 (1018) : 1376-1384.
8Celli N, Gaiani S, Piscagla F, et al. Characterization of liver lesions by real time contrast enhanced uhrasonography [J]. Eur J Gastroenterol Hepatol, 2007,19 (1) : 3-14.
9Xu HX, Xie XY, Lu MD, et al. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma ≤2 cm [J]. J Clin Ultrasound, 2008,36 (5) : 257-266.
10Kudo M. Early detection and characterization of hepatocellular carcinoma: value of imaging muhistep human hepatocarcinogenesis [J]. Intervirology, 2006,49 (1-2) : 64- 69.
